CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
2015 · Scientific Reports · 327 citations
https://doi.org/10.1038/srep11483
J
Justus B. Cohen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
210
Papers
5.8K
Citations
43
h-index
109
i10-index
Justus B. Cohen is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Virus-based gene therapy research & Herpesvirus Infections and Treatments & Plant Virus Research Studies. The author has an h-index of 43, co-authored 179 publications.
ORCID: 0000-0003-1208-1883Papers by this author
worksEngineered HSV vector achieves safe long-term transgene expression in the central nervous system
2017 · Scientific Reports · 50 citations
https://doi.org/10.1038/s41598-017-01635-1
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity
2014 · Molecular Therapy — Oncolytics · 43 citations
https://doi.org/10.1038/mto.2014.10
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes
2017 · Molecular Therapy — Methods & Clinical Development · 23 citations
https://doi.org/10.1016/j.omtm.2017.06.001
Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies
2020 · Molecular Therapy — Methods & Clinical Development · 22 citations
https://doi.org/10.1016/j.omtm.2019.12.013
Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment
2021 · Molecular Therapy — Oncolytics · 13 citations
https://doi.org/10.1016/j.omto.2021.07.009
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat